Citations

Mayo Clinic

Clear

2356 citation(s) found for "K, Long".

LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS
Amling, Christopher L. , Blute, Michael L., Bergstralh, Erik J., Seay, Thomas, Slezak, Jeffrey M., Zincke, Horst

Journal of Urology | January 17, 2006 | Volume: 164 | Issue: 1 | Pages: 101-105

10.1016/s0022-5347(05)67457-5 Get It

CYSTIC RENAL CELL CARCINOMA IS CURED BY RESECTION: A STUDY OF 24 CASES WITH LONG-TERM FOLLOWUP
Corica, Federico A., Iczkowski, Kenneth A. , Cheng, Liang , Zincke, Horst, Blute, Michael L., Wendel, Amy J., Sebo, Thomas J., Neumann, Roxann M., Bostwick, David G., Cheng, Liang

Journal of Urology | January 17, 2006 | Volume: 161 | Issue: 2 | Pages: 408-411

10.1016/s0022-5347(01)61903-7 | PMID 9915413 Get It

Ureteroscopy: Current Practice and Long-Term Complications
Harmon, William J., Sershon, Peter D., Blute, Michael L., Patterson, David E., Segura, Joseph W.

Journal of Urology | January 17, 2006 | Volume: 157 | Issue: 1 | Pages: 28-32

10.1016/s0022-5347(01)65272-8 | PMID 8976208 Get It

Long-term Followup and Evaluation of Primary Realignment of Posterior Urethral Disruptions
Elliott, Daniel S. , Barrett, David M.

Journal of Urology | January 17, 2006 | Volume: 157 | Issue: 3 | Pages: 814-816

10.1016/s0022-5347(01)65051-1 Get It

LONG-TERM OUTCOME IN PATIENTS WITH pTxN+ ADENOCARCINOMA OF PROSTATE TREATED WITH RADICAL PROSTATECTOMY AND EARLY ANDROGEN ABLATION
Seay, Thomas, Blute, Michael L., Zincke, Horst

Journal of Urology | January 17, 2006 | Volume: 159 | Issue: 2 | Pages: 357-364

10.1016/s0022-5347(01)63917-x | PMID 9649239 Get It

MAYO CLINIC LONG-TERM ANALYSIS OF THE FUNCTIONAL DURABILITY OF THE AMS 800 ARTIFICIAL URINARY SPHINCTER: A REVIEW OF 323 CASES
Elliott, Daniel S. , Barrett, David M.

Journal of Urology | January 17, 2006 | Volume: 159 | Issue: 4 | Pages: 1206-1208

10.1016/s0022-5347(01)63557-2 Get It

Long Term Use of Megestrol Acetate by Cancer Survivors for the Treatment of Hot Flashes
Quella, Susan K., Loprinzi, Charles L. , Sloan, Jeff A. , Vaught, Nancy L., DeKrey, Wanda L., Fischer, Tammy, Finck, Gwen, Pierson, Namali, Pisansky, Thomas M.

Journal of Urology | January 17, 2006 | Volume: 161 | Issue: 1 | Pages: 360-360

10.1016/s0022-5347(01)62161-x Get It

Ureteropelvic Junction Obstruction with a Simultaneous Renal Calculus: Long-Term Followup
Husmann, Douglas A. , Milliner, Dawn S. , Segura, Joseph W.

Journal of Urology | January 17, 2006 | Volume: 153 | Issue: 5 | Pages: 1399-1402

10.1016/s0022-5347(01)67412-3 Get It

Ureteropelvic Junction Obstruction with Concurrent Renal Pelvic Calculi in the Pediatric Patient: A Long-term Followup
Husmann, Douglas A. , Milliner, Dawn S. , Segura, Joseph W.

Journal of Urology | January 17, 2006 | Volume: 156 | Issue: 2S | Pages: 741-743

10.1016/s0022-5347(01)65802-6 Get It

Impact of Prosthesis-Patient Mismatch on Long-Term Survival in Patients With Small St Jude Medical Mechanical Prostheses in the Aortic Position
Mohty-Echahidi, Dania, Malouf, Joseph F., Girard, Steve E., Schaff, Hartzell V. , Grill, Diane E. , Miller, Fletcher A., Girard, Steven , Enriquez‐Sarano, Maurice , Enriquez-Sarano, Maurice , Schaff, Hartzell

Circulation | January 16, 2006 | Volume: 113 | Issue: 3 | Pages: 420-426

10.1161/circulationaha.105.546754 | PMID 16415379 Get It

Background— The impact of aortic prosthesis-patient mismatch (P-PtM) on long-term survival is unclear. Methods and Results— Between 1985 and 2000, 388 patients at Mayo Clinic in Rochester, Minn, underwent aortic valve replacement (AVR) with 19- or 21-mm St Jude Medical prostheses and had transthoracic echocardiography within 1 year after AVR. Mean age of patients was 62±13 years; 69% were female. Prosthesis effective orifice area (EOA) was derived from the continuity equation. P-PtM was classified as severe (indexed EOA ≤0.60 cm 2 /m 2 ), moderate (0.60 cm 2 /m 2 <indexed EOA≤0.85 cm 2 /m 2 ), or not hemodynamically significant (indexed EOA >0.85 cm 2 /m 2 ). P-PtM was severe in 66 patients (17%), moderate in 168 (43%), and not hemodynamically significant in 154 (40%). Patients with severe P-PtM had a significantly larger body surface area ( P <0.0001), higher mean gradient ( P <0.0001), lower preoperative ( P <0.0001) and postoperative ( P <0.0001) ejection fractions, and lower stroke volume ( P <0.0001) and more often received a 19-mm prosthesis ( P =0.0008) than patients with moderate or no hemodynamically significant mismatch. For patients with severe mismatch, 5-year survival rates (72±6%) and 8-year survival rates (41±8%) were significantly less than for patients with moderate mismatch (80±3% and 65±5%; P =0.026) or no hemodynamically significant mismatch (85±3% and 74±5%; P =0.002). On multivariate analysis after adjustment for other predictors of outcome, severe mismatch was associated with higher mortality (hazard ratio 2.18; 95% confidence interval 1.24 to 3.85; P =0.007) and higher incidence of congestive heart failure (hazard ratio 3.1; 95% confidence interval 1.3 to 7.4; P =0.009) than no hemodynamically significant mismatch. Conclusions— Severe P-PtM is an independent predictor of higher long-term mortality and congestive heart failure in patients with small St Jude Medical aortic valve prostheses. For patients undergoing AVR who are at risk of severe mismatch, every effort should be made to use a larger prosthesis or to consider a prosthesis with a larger EOA.